Product Overview

ZyhCG is a pharmaceutical product that contains Human Chorionic Gonadotropin (HCG), a hormone produced during pregnancy. German Remedies Private Ltd manufactures ZyhCG as a lyophilized powder supplied in a single‑vial format for treating female infertility. Each box contains one vial with 5,000 IU of HCG, which must be reconstituted with sterile diluent before use. The indication is ovulation induction in women with ovulatory dysfunction or those undergoing assisted reproductive techniques. The product is regulated for clinical safety and efficacy. The vial is intended for intramuscular or subcutaneous injection after proper reconstitution, and dosing is determined by a healthcare professional based on individual patient factors. Storage requirements include refrigeration at 2–8 °C until use, and the solution should be inspected for clarity before administration.

What is ZyhCG (HCG (Human Chorionic Gonadotropin))

Human Chorionic Gonadotropin, abbreviated HCG, is a glycoprotein hormone composed of alpha and beta subunits that mimics luteinizing hormone (LH) in the body. In women, HCG binds to receptors on ovarian follicle cells, triggering final egg maturation and stimulating estrogen production. This signaling is crucial for ovulation and for preparing the uterine lining for implantation. Clinically, synthetic HCG is used to induce ovulation in women with insufficient endogenous LH surge and to support luteal phase function in assisted reproduction. The hormone is regulated as a therapeutic agent for female infertility. Its pharmacological profile includes a half‑life of approximately 30 hours, allowing a single dose to sustain luteal support for several days. Understanding this mechanism helps clinicians time administration precisely to optimize follicular development and pregnancy rates.

Uses and Benefits

ZyhCG is prescribed primarily to induce ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders. By stimulating the LH surge, the medication increases the chance of egg release, thereby improving conception rates when combined with timed intercourse or intrauterine insemination. In IVF cycles, HCG can provide luteal phase support after egg retrieval, enhancing implantation likelihood. The drug offers a predictable dosing schedule, high purity, and a well‑characterized safety profile under medical supervision. Patients often experience restored menstrual regularity and improved hormonal balance, contributing to overall reproductive health. Detailed clinical data are available through the NIH’s reproductive hormone database.

How It Works

The mechanism of HCG involves binding to the LH receptor on theca and granulosa cells within the ovarian follicle. This activation triggers intracellular pathways that promote androgen synthesis, which is then aromatized to estrogen, leading to oocyte maturation. Simultaneously, HCG stimulates the corpus luteum to produce progesterone, preparing the endometrium for implantation. In assisted reproduction, the hormone is administered when follicles reach 18–20 mm on ultrasound, ensuring optimal egg maturity. HCG’s half‑life is roughly 30 hours, allowing a single dose to maintain luteal support for several days. Precise timing of injection improves follicular development and increases pregnancy rates.

Dosage Guidelines

Dosage of ZyhCG is individualized according to age, ovarian reserve, and prior response to stimulation. The standard ovulation induction regimen consists of a single 5,000 IU intramuscular injection once the dominant follicle measures at least 18 mm. Some protocols add a supplemental 1,000 IU dose 24 hours later to enhance ovulation rates. For luteal phase support after egg retrieval, a daily subcutaneous dose of 500–1,000 IU is recommended for up to 14 days. All administrations must be performed under medical supervision, with monitoring of hormone levels and follicular growth via blood tests and ultrasound. Adjustments may be necessary in cases of ovarian hyperstimulation syndrome. Further regulatory guidance can be found in FDA drug labeling resources.

Side Effects

Common side effects of ZyhCG include mild headache, abdominal discomfort, and injection site reactions such as redness or swelling. Less frequent effects are nausea, fatigue, and breast tenderness. Rare but serious complications can involve ovarian hyperstimulation syndrome (OHSS), manifested by rapid weight gain, shortness of breath, and severe pelvic pain, which require immediate medical attention. Allergic reactions, though uncommon, may present as rash, itching, or difficulty breathing. For detailed safety data, consult the NIH’s hormone therapy resources or the FDA.

Warnings and Precautions

ZyhCG is contraindicated in patients with known hypersensitivity to HCG or any excipients in the formulation. Pregnant or breastfeeding women should avoid use unless a physician explicitly approves. Individuals with a history of hormone‑sensitive cancers, thromboembolic disorders, or uncontrolled thyroid disease require careful evaluation prior to treatment. Concomitant use of certain fertility medications may increase the risk of multiple pregnancies, necessitating close monitoring. The vial must be stored refrigerated at 2–8 °C until reconstitution, and any solution that appears cloudy or discolored should be discarded. Proper reconstitution volume and injection technique are essential for accurate dosing; always follow the manufacturer’s instructions. Additional labeling details are available on the German Remedies website or through a licensed pharmacist. For patient‑focused information, see MedlinePlus.

Frequently Asked Questions

Q: What is the recommended storage condition for ZyhCG before use?
A: ZyhCG must be stored refrigerated at 2–8 °C in its original, unopened vial. Once reconstituted, the solution can be kept at room temperature for up to 24 hours, protected from light, and should be used within that window. Always inspect the solution for clarity before administration, and discard any vial that shows discoloration or particles.

Q: Can ZyhCG be self‑administered at home?
A: Self‑administration is possible only after a qualified healthcare professional has demonstrated the correct reconstitution and injection technique. Patients must verify the prescribed dose, use aseptic technique, and have a plan for contacting a clinician in case of adverse reactions. Even when used at home, regular monitoring by a medical provider is essential to ensure safety and efficacy.

Q: How does ZyhCG differ from other ovulation induction agents?
A: Unlike oral agents such as clomiphene citrate, which act on the pituitary gland, HCG mimics luteinizing hormone directly and is administered by injection. This results in a more predictable follicular response and is often preferred for patients who do not respond to oral therapy. Additionally, HCG can be used for luteal phase support in IVF cycles, a function not provided by oral medications.

Q: Is ZyhCG safe for women with polycystic ovary syndrome (PCOS)?
A: Clinical studies indicate that ZyhCG can be used safely in PCOS patients when dosing is carefully titrated and follicular development is monitored with ultrasound. However, women with PCOS have an increased risk of ovarian hyperstimulation syndrome, so clinicians must start with lower doses and adjust based on response. Proper monitoring minimizes complications while allowing ovulation induction.

Q: Where can I find more information about HCG therapy?
A: Authoritative sources such as the National Institutes of Health (NIH) provide evidence‑based guidance on HCG use in reproductive medicine. The U.S. Food and Drug Administration (FDA) offers detailed drug labeling and safety alerts, while MedlinePlus presents patient‑friendly summaries. Professional fertility societies also publish consensus statements that complement these resources.

Related Products

• Azelastine Nasal Spray (Generic)
• Arzep Nasal Spray (Azelastine)
• Vigora 100 mg (Sildenafil Citrate)
• Vigora Tablet (Sildenafil Citrate)
• Vigora Lido Spray (Lidocaine)
• Vigore Gold 100 mg (Sildenafil Citrate)
• Vigore Force 80 mg (Sildenafil/Dapoxetine)
• Tadora 20 mg (Tadalafil)
• Vigora 50 mg (Sildenafil Citrate)
• Tadora Force 80 mg(Tadalafil/Dapoxetine)
• ZyhCG 10000 (HCG 10000iu)
• ZyhCG 5000 (HCG 5000iu)